Javascript must be enabled to continue!
Exploring the classification of cancer cell lines from multiple omic views
View through CrossRef
Background
Cancer classification is of great importance to understanding its pathogenesis, making diagnosis and developing treatment. The accumulation of extensive omics data of abundant cancer cell line provide basis for large scale classification of cancer with low cost. However, the reliability of cell lines as in vitro models of cancer has been controversial.
Methods
In this study, we explore the classification on pan-cancer cell line with single and integrated multiple omics data from the Cancer Cell Line Encyclopedia (CCLE) database. The representative omics data of cancer, mRNA data, miRNA data, copy number variation data, DNA methylation data and reverse-phase protein array data were taken into the analysis. TumorMap web tool was used to illustrate the landscape of molecular classification.The molecular classification of patient samples was compared with cancer cell lines.
Results
Eighteen molecular clusters were identified using integrated multiple omics clustering. Three pan-cancer clusters were found in integrated multiple omics clustering. By comparing with single omics clustering, we found that integrated clustering could capture both shared and complementary information from each omics data. Omics contribution analysis for clustering indicated that, although all the five omics data were of value, mRNA and proteomics data were particular important. While the classifications were generally consistent, samples from cancer patients were more diverse than cancer cell lines.
Conclusions
The clustering analysis based on integrated omics data provides a novel multi-dimensional map of cancer cell lines that can reflect the extent to pan-cancer cell lines represent primary tumors, and an approach to evaluate the importance of omic features in cancer classification.
Title: Exploring the classification of cancer cell lines from multiple omic views
Description:
Background
Cancer classification is of great importance to understanding its pathogenesis, making diagnosis and developing treatment.
The accumulation of extensive omics data of abundant cancer cell line provide basis for large scale classification of cancer with low cost.
However, the reliability of cell lines as in vitro models of cancer has been controversial.
Methods
In this study, we explore the classification on pan-cancer cell line with single and integrated multiple omics data from the Cancer Cell Line Encyclopedia (CCLE) database.
The representative omics data of cancer, mRNA data, miRNA data, copy number variation data, DNA methylation data and reverse-phase protein array data were taken into the analysis.
TumorMap web tool was used to illustrate the landscape of molecular classification.
The molecular classification of patient samples was compared with cancer cell lines.
Results
Eighteen molecular clusters were identified using integrated multiple omics clustering.
Three pan-cancer clusters were found in integrated multiple omics clustering.
By comparing with single omics clustering, we found that integrated clustering could capture both shared and complementary information from each omics data.
Omics contribution analysis for clustering indicated that, although all the five omics data were of value, mRNA and proteomics data were particular important.
While the classifications were generally consistent, samples from cancer patients were more diverse than cancer cell lines.
Conclusions
The clustering analysis based on integrated omics data provides a novel multi-dimensional map of cancer cell lines that can reflect the extent to pan-cancer cell lines represent primary tumors, and an approach to evaluate the importance of omic features in cancer classification.
Related Results
Complex Collision Tumors: A Systematic Review
Complex Collision Tumors: A Systematic Review
Abstract
Introduction: A collision tumor consists of two distinct neoplastic components located within the same organ, separated by stromal tissue, without histological intermixing...
Frequency of Common Chromosomal Abnormalities in Patients with Idiopathic Acquired Aplastic Anemia
Frequency of Common Chromosomal Abnormalities in Patients with Idiopathic Acquired Aplastic Anemia
Objective: To determine the frequency of common chromosomal aberrations in local population idiopathic determine the frequency of common chromosomal aberrations in local population...
Small Cell Lung Cancer and Tarlatamab: A Meta-Analysis of Clinical Trials
Small Cell Lung Cancer and Tarlatamab: A Meta-Analysis of Clinical Trials
Abstract
Introduction
Tarlatamab is a Delta-like ligand 3 (DLL3) -directed bispecific T-cell engager recently approved for use in patients with advanced small cell lung cancer (SCL...
Are Cervical Ribs Indicators of Childhood Cancer? A Narrative Review
Are Cervical Ribs Indicators of Childhood Cancer? A Narrative Review
Abstract
A cervical rib (CR), also known as a supernumerary or extra rib, is an additional rib that forms above the first rib, resulting from the overgrowth of the transverse proce...
Abstract 2963: The Foxp3 transcription factor expression in human gynecologic cancer cell lines
Abstract 2963: The Foxp3 transcription factor expression in human gynecologic cancer cell lines
Abstract
Objectives: The forkhead box protein 3 (Foxp3) transcription factor is considered as a master control gene for the function of regulatory T cells. However, ...
Diagnostic Rate of the Cancer by BDORT Utilizing the Cancer Slide
Diagnostic Rate of the Cancer by BDORT Utilizing the Cancer Slide
Purpose:
To make a diagnosis of cancer with BDORT (resonance test), we can choose two methods. One is to use a chemical agent like Integrin α5β1 or Oncogene C-f...
Abstract 76: KPNA7 nuclear import protein - a critical regulator of cancer cell growth
Abstract 76: KPNA7 nuclear import protein - a critical regulator of cancer cell growth
Abstract
Background. In eukaryotic cells, the nucleus is separated from the cytosol by the nuclear envelope, thus requiring a specific machinery for the transport of...
Abstract 1416: Synergistic cytotoxicity of metformin cotreatment with paclitaxel or carboplatin in triple negative breast cancer cell lines
Abstract 1416: Synergistic cytotoxicity of metformin cotreatment with paclitaxel or carboplatin in triple negative breast cancer cell lines
Abstract
Metformin is an oral antidiabetic drug with a putative antineoplastic effect in breast cancer; however, its efficacy in clinical trials has been mixed. Trip...

